Large-scale testing (Phase 3)Study completedNCT00114361
What this trial is testing
48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
Who this might be right for
Hepatitis B
Foundation for Liver Research 138